Your browser doesn't support javascript.
loading
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).
Wang, Feng; He, Ming-Ming; Xiao, Jian; Zhang, Yan-Qiao; Yuan, Xiang-Lin; Fang, Wei-Jia; Zhang, Yan; Wang, Wei; Hu, Xiao-Hua; Ma, Zhi-Gang; Yao, Yi-Chen; Zhuang, Zhi-Xiang; Zhou, Fu-Xiang; Ying, Jie-Er; Yuan, Ying; Zou, Qing-Feng; Guo, Zeng-Qing; Wu, Xiang-Yuan; Jin, Ying; Mai, Zong-Jiong; Wang, Zhi-Qiang; Qiu, Hong; Guo, Ying; Shi, Si-Mei; Chen, Shuang-Zhen; Luo, Hui-Yan; Zhang, Dong-Sheng; Wang, Feng-Hua; Li, Yu-Hong; Xu, Rui-Hua.
Affiliation
  • Wang F; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • He MM; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, P.R. China.
  • Xiao J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Zhang YQ; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, P.R. China.
  • Yuan XL; The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P.R. China.
  • Fang WJ; Harbin Medical University Cancer Hospital, Harbin, P.R. China.
  • Zhang Y; Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
  • Wang W; The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Hu XH; The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P.R. China.
  • Ma ZG; The First People's Hospital of Foshan, Foshan, P.R. China.
  • Yao YC; The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China.
  • Zhuang ZX; Harbin Medical University Cancer Hospital, Harbin, P.R. China.
  • Zhou FX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Ying JE; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, P.R. China.
  • Yuan Y; The Second Affiliated Hospital of Soochow University, Soochow, P.R. China.
  • Zou QF; Zhongnan Hospital of Wuhan University, Hubei Clinical Cancer Study Center, Wuhan, P.R. China.
  • Guo ZQ; Zhejiang Cancer Hospital, Hangzhou, P.R. China.
  • Wu XY; The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Jin Y; Affiliated Tumor Hospital of Guangzhou Medical University, Guangzhou, P.R. China.
  • Mai ZJ; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, P.R. China.
  • Wang ZQ; The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P.R. China.
  • Qiu H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Guo Y; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, P.R. China.
  • Shi SM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Chen SZ; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, P.R. China.
  • Luo HY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Zhang DS; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, P.R. China.
  • Wang FH; Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
  • Li YH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
Clin Cancer Res ; 28(19): 4232-4239, 2022 10 03.
Article in En | MEDLINE | ID: mdl-35929990
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Colorectal Neoplasms / Colonic Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Colorectal Neoplasms / Colonic Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article